BACH2
protein-codingBTB domain and CNC homolog 2, the group of BTB domain containing|Basic leucine zipper proteins
Gene summary
Enables sequence-specific double-stranded DNA binding activity. Involved in primary adaptive immune response involving T cells and B cells. Located in cytosol and nucleoplasm. Implicated in immunodeficiency 60. [provided by Alliance of Genome Resources, Jun 2026]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~370.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0032723
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0032723
Submitter: ClinGen
BACH2 is a transcription factor that forms a heterodimer with MAF transcription factors to bind MAF recognition elements (MAREs) in the promoters of target genes. Bach2 deficiency significantly affected the expression of genes with super-enhancer architecture compared to those with TEs or no enhancer mark in T cells. *BACH2* was first reported in relation to in 2017 (PMID: 28530713). A de novo heterozygous c.71T>C transition in the BACH2 gene, resulting in a leu24-to-pro (L24P) substitution was detected in a female with lymphocyte maturation defects, causing immunoglobulin deficiency and intestinal inflammation. Recurrent sinopulmonary infections, bronchiectasis and intestinal inflammation were also evident in a father and his daughter with a heterozygous point mutation in BACH2, c.2362G>A. Experimental evidence also supports a haploinsufficient model. Bach2+/− mice had a significant reduction in FoxP3+ cells together with significant increases in CCR9+ and β7-integrin+ cells in CD4+ T cells. Immunized Bach2+/− mice exhibited minimal induction of both IgG1 class switched-B220hiCD138− B cells and B220loCD138+ plasma cells compared to WT mice (PMID: 28530713). The immunophenotype of patients with mutations in BACH2 consisted of compromised Treg cells, enhanced TH1 differentiation, impaired proliferation and defective B cell maturation and Ig class switching. Silencing BACH2 in healthy control B cells, significantly suppressed in vitro class switch recombination towards the IgG and IgA isotypes. In summary, there is moderate evidence to support this gene-disease relationship. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. Gene Clinical Validity Standard Operating Procedures (SOP) - SOP9
Inheritance Pattern: AD
Disease ID:MONDO:0032723
Submitter: Illumina
Inheritance Pattern: AD
Disease ID:MONDO:0032723
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0032723
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Allergy/Immunology/Infectious
Intervention: Allergy/Immunology/Infectious
Rationale: Individuals may manifest with findings such as inflammatory bowel disease and recurrent sinopulmonary infections and antiinfectious prophylaxis and early and aggressive treatment of infections may be beneficial
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to BACH2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_021813.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 199 | 4 | 204 | ||
| missense | 1 | 337 | 29 | 1 | 368 | |
| nonsense | 2 | 2 | ||||
| start loss | 0 | |||||
| frameshift | 4 | 4 | ||||
| splice donor/acceptor (+/-2bp) | 1 | 1 | ||||
| Total | 1 | 0 | 345 | 228 | 5 | 579 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_068585.1 | 4 | MANE Select | |
| Ensembl | ENSP00000257749.4 | 4 | MANE Select | |
| RefSeq | NP_001164265.1 | 4 | Standard | |
| Ensembl | ENSP00000345642.3 | 4 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- negative regulation of transcription by RNA polymerase II
- regulation of transcription, DNA-templated
- import into nucleus
Molecular Function
- RNA polymerase II distal enhancer sequence-specific DNA binding
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA-binding transcription repressor activity, RNA polymerase II-specific
- DNA-binding transcription factor activity
Cellular Component
- nucleus
- cytosol
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000257749
- Coding exons
- 4
- Length
- 370380
- Individuals with no LoFs
- 125739
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 4
- Defined
- 125743
- p
- 0.0000159
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 2.30 | 361 | 506 | 0.713 | 0.0000313 | 5523 |
| Missense (PolyPhen) | 83 | 165.59 | 0.50125 | 1858 | ||
| Synonymous | 0.00675 | 219 | 219 | 0.999 | 0.0000151 | 1673 |
| Loss of Function | 4.46 | 2 | 27.0 | 0.0740 | 0.00000133 | 343 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0.00010 | 0.000099 | rare |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.000018 | 0.000018 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Transcriptional regulator that acts as repressor or activator (By similarity). Binds to Maf recognition elements (MARE) (By similarity). Plays an important role in coordinating transcription activation and repression by MAFK (By similarity). Induces apoptosis in response to oxidative stress through repression of the antiapoptotic factor HMOX1 (PubMed:17018862). Positively regulates the nuclear import of actin (By similarity). {ECO:0000250|UniProtKB:P97303, ECO:0000269|PubMed:17018862}.;
Recessive Scores
- pRec
- 0.176
Intolerance Scores
- LoFtool
- 0.0845
- RVIS EVS
- -0.62
- RVIS percentile EVS
- 17.45
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.761
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |